These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications. Venkatesan V; Christopher AC; Karuppusamy KV; Babu P; Alagiri MKK; Thangavel S J Vis Exp; 2022 Aug; (186):. PubMed ID: 36036597 [TBL] [Abstract][Full Text] [Related]
25. Efficient ZFN-Mediated Stop Codon Integration into the CCR5 Locus in Hematopoietic Stem Cells: A Possible Source for Intrabone Marrow Cell Transplantation. Chattong S; Chaikomon K; Chaiya T; Tangkosakul T; Palavutitotai N; Anusornvongchai T; Manotham K AIDS Res Hum Retroviruses; 2018 Jul; 34(7):575-579. PubMed ID: 29575905 [TBL] [Abstract][Full Text] [Related]
26. Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking study. Kim S; Kim N; Presson AP; Metzger ME; Bonifacino AC; Sehl M; Chow SA; Crooks GM; Dunbar CE; An DS; Donahue RE; Chen IS Cell Stem Cell; 2014 Apr; 14(4):473-85. PubMed ID: 24702996 [TBL] [Abstract][Full Text] [Related]
30. Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System. Devaraju N; Rajendiran V; Ravi NS; Mohankumar KM Methods Mol Biol; 2022; 2429():307-331. PubMed ID: 35507170 [TBL] [Abstract][Full Text] [Related]
31. Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break. Rogers GL; Chen HY; Morales H; Cannon PM Mol Ther; 2019 Oct; 27(10):1726-1736. PubMed ID: 31540849 [TBL] [Abstract][Full Text] [Related]
32. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I. Gomez-Ospina N; Scharenberg SG; Mostrel N; Bak RO; Mantri S; Quadros RM; Gurumurthy CB; Lee C; Bao G; Suarez CJ; Khan S; Sawamoto K; Tomatsu S; Raj N; Attardi LD; Aurelian L; Porteus MH Nat Commun; 2019 Sep; 10(1):4045. PubMed ID: 31492863 [TBL] [Abstract][Full Text] [Related]
33. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Mock U; Machowicz R; Hauber I; Horn S; Abramowski P; Berdien B; Hauber J; Fehse B Nucleic Acids Res; 2015 Jun; 43(11):5560-71. PubMed ID: 25964300 [TBL] [Abstract][Full Text] [Related]
35. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow. Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919 [TBL] [Abstract][Full Text] [Related]
36. Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. Zhen A; Peterson CW; Carrillo MA; Reddy SS; Youn CS; Lam BB; Chang NY; Martin HA; Rick JW; Kim J; Neel NC; Rezek VK; Kamata M; Chen ISY; Zack JA; Kiem HP; Kitchen SG PLoS Pathog; 2017 Dec; 13(12):e1006753. PubMed ID: 29284044 [TBL] [Abstract][Full Text] [Related]
37. Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Wang J; Exline CM; DeClercq JJ; Llewellyn GN; Hayward SB; Li PW; Shivak DA; Surosky RT; Gregory PD; Holmes MC; Cannon PM Nat Biotechnol; 2015 Dec; 33(12):1256-1263. PubMed ID: 26551060 [TBL] [Abstract][Full Text] [Related]
38. Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Pavani G; Laurent M; Fabiano A; Cantelli E; Sakkal A; Corre G; Lenting PJ; Concordet JP; Toueille M; Miccio A; Amendola M Nat Commun; 2020 Jul; 11(1):3778. PubMed ID: 32728076 [TBL] [Abstract][Full Text] [Related]
39. Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: effects of a retroviral-mediated gene transfer protocol and implications for gene therapy. Goebel WS; Yoder MC; Pech NK; Dinauer MC Exp Hematol; 2002 Nov; 30(11):1324-32. PubMed ID: 12423686 [TBL] [Abstract][Full Text] [Related]
40. Novel strategy for successful long-term hematopoietic recovery after transplanting a limited number of hematopoietic stem/progenitor cells. Lee H; Park HS; Choi OK; Oh JE; Chung SS; Jung HS; Park KS Biol Blood Marrow Transplant; 2014 Sep; 20(9):1282-9. PubMed ID: 24980112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]